Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Chhaya Makhija, MD, DipABLM Board-Certified Endocrinologist | Lifestyle Medicine Physician | Founder, Unified Endocrine & Diabetes Care Lafayette Fresno California Telemedicine (including Silicon Valley, Palo Alto, Menlo Park, San Francisco, Walnut Creek, Oakland, Sacramento) Watch or Listen to the Full Episode For a deeper dive into the science and real-world clinical nuance:
adults without diabetes used a GLP-1 (drug) in 2022, wrote the research team led by Michelle Dowsey, an epidemiologist with the University of Melbourne in Australia
PMC 7979486
Verrotti A, Trotta D, Morgese G, Chiarelli F: Valproate-induced hyperammonemic encephalopathy
The effect of glucagon-like peptide-1 receptor agonists on diabetic retinopathy at a tertiary care center
US$ 26.60
US$ 23.96
US$ 23.59
US$ 27.34
US$ 27.45
US$ 25.37
US$ 26.11
US$ 23.37
US$ 21.02
US$ 21.25
US$ 20.68
